Therapies, Research Funding, and Racial Diversity in Essential Tremor: A Systematic Review of the Literature.

ABSTRACT:

Background

Essential tremor (ET) is one of the most common tremor disorders in the world. Despite this, only one medication, propranolol, is approved by the Food and Drug Administration to treat it.

Objectives

We analyzed controlled clinical trials in ET, spanning the last 50 years, to identify potential shortcomings in the therapeutic clinical pipeline.

Methods

Outcomes reviewed included demographics (specifically gender and race), therapeutic modalities, funding information, location of research, and trends over time. Clinical trials published in English were identified in scientific databases (Pubmed, SCOPUS, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform from 197

SUBMITTER: Zesiewicz T 

PROVIDER: S-EPMC9346245 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature